Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest Drugs in Development and Pipeline Prospector News of Cannassure Therapeutics.

    Client Virtual Booth

    CANNASSURE THERAPEUTICS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Cannassure Therapeutics
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Hahadarim 2 Ashdod, Ashdod 7712102, IL
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://cannassure.life/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/cannassure/
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    • Deals
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    Lipidor Submits New Patent Application and Expands Collaboration with Cannassure Using Lipidor's AKVANO® Technology for Medicinal Cannabis Products

    Details:

    Based on new IP (intellectual property), the scope of the collaboration agreement has expanded to include a new patent family covering innovative new AKVANO® topical formulations.


    Lead Product(s): Cannabidiol

    Therapeutic Area: Dermatology Product Name: Undisclosed

    Highest Development Status: PreclinicalProduct Type: Small molecule

    Recipient: Lipidor AB

    Deal Size: $0.4 million Upfront Cash: Undisclosed

    Deal Type: Expanded Collaboration October 29, 2021

    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    • Deals
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    Lipidor and Cannassure Enter Exclusive Licensing Agreement Regarding Topical Medical Cannabis Products Based on Lipidor's AKVANO® Technology

    Details:

    Under the agreement, Cannassure has the exclusive right to use Lipidor’s proprietary drug delivery technology AKVANO®in medicinal cannabis products for the treatment of selected indications such as psoriasis, atopic dermatitis, pain and lesions.


    Lead Product(s): Cannabidiol

    Therapeutic Area: Dermatology Product Name: Undisclosed

    Highest Development Status: UndisclosedProduct Type: Small molecule

    Recipient: Lipidor AB

    Deal Size: $0.4 million Upfront Cash: Undisclosed

    Deal Type: Collaboration January 18, 2021

    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search